NCT04701710View on ClinicalTrials.gov

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

December 18, 2020

Study Completion Date

December 31, 2020

Conditions
Covid19SARS (Severe Acute Respiratory Syndrome)
Interventions
DRUG

Ivermectin / Iota-Carrageenan

The EG received Ivermectin orally 2 drops of 6 mg = 12 mg every 7 days, and Iota-Carrageenan 6 sprays per day for 4 weeks.

Trial Locations (1)

4000

SI.PRO.SA, Ministerio de Salud Pública, San Miguel de Tucumán

All Listed Sponsors
lead

Maria de los Angeles Peral de Bruno

OTHER_GOV

NCT04701710 - Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan | Biotech Hunter | Biotech Hunter